Search

everythinglearnresearchcommunity

for

Search:↓

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

JAK inhibitors show promise in treating difficult skin diseases.

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Azathioprine may be an effective treatment for severe hair loss.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Canakinumab's effect on COVID-19 outcomes is unclear.

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Cyclosporine effectively treated a woman's stubborn skin condition.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.